Funding Rounds
IsomAb

IsomAb Seed (2024, $9M)

IsomAb

Developer of antibodies to treat diabetic peripheral arterial disease.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Seed

Raised Amount: $9.47M

Investors